You are here: Industry Insights > Rentschler Biopharma

News List

Rentschler Biopharma and Vetter Unveil Xpert Alliance, a Joint Visualization of their Successful Strategic Collaboration b3cnewswire
March 30, 2022
Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations...
Rentschler Biopharma Strengthens Leadership Team contractpharma
February 04, 2022
Hires executives with strong experience in strategy, operations and project management.
Rentschler Biopharma and ATUM Ink Licensing Agreement contractpharma
October 16, 2020
Leap-In Transposase technology will be integrated into Rentschler’s in-house process to complement existing CLD offering.
Rentschler Biopharma Enters COVID-19 Vax Agreement with BioNTech contractpharma
October 10, 2020
Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, has entered an agreement to serve as CDMO partner for BioNTech.
Rentschler Biopharma and Vetter Team Up with Joint Goal to Simplify Processes and Optimize Time-To-Market b3cnewswire
July 08, 2020
Vetter and Rentschler Biopharma, two globally operating Contract Development and Manufacturing Organizations (CDMOs), today announced their strategic collaboration, to enhance their services and offer complementary skills and experience along the biophar
Rentschler Biopharma and Vetter Enter Partnership contractpharma
July 07, 2020
Two CDMOs team up with joint goal to simplify processes and optimize time-to-market.
Rentschler Biopharma to Purchase U.S. Manufacturing Site from Shire americanpharmaceuticalreview
December 18, 2018
Rentschler Biopharma announced the company has signed an agreement to purchase a manufacturing facility from an affiliate Shire plc in Milford near Boston, MA......